Caribou Biosciences, Inc. (CRBU)
Caribou Biosciences Market Cap : 190.38M for March 19, 2026
Market Cap Chart
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
| EyePoint Plc | 1.151B |
| SELLAS Life Sciences Group, Inc. | 885.47M |
| GT Biopharma, Inc. | 13.42M |
| Aclaris Therapeutics, Inc. | 452.87M |
| CytomX Therapeutics, Inc. | 813.49M |
Market Cap Related Metrics
| PS Ratio | 16.49 |
| Price to Book Value | 1.558 |
| Price | 1.97 |
| Earnings Yield | -80.63% |